[HAPSENG] QoQ Annualized Quarter Result on 30-Apr-2004 [#1]

Stock
[HAPSENG] HAP SENG CONSOLIDATED BHD
Announcement Date
22-Jun-2004
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jan-2005
Quarter
30-Apr-2004 [#1]
Profit Trend
QoQ- 42.99%
YoY- 56.07%
Quarter Report
Latest QR
Upcoming QR
HAPSENG's Result
HAPSENG's Financial Summary
View:
Show?
Annualized Quarter Result
31/01/05 31/10/04 31/07/04 30/04/04 31/01/04 31/10/03 31/07/03 CAGR
Revenue 1,225,368 1,204,900 1,137,452 1,066,596 875,035 877,088 854,344 27.04%
PBT 208,184 217,472 215,536 216,380 178,706 171,905 158,984 19.59%
Tax -67,548 -65,709 -59,294 -52,312 -63,968 -57,522 -54,158 15.79%
NP 140,636 151,762 156,242 164,068 114,738 114,382 104,826 21.53%
-
NP to SH 140,636 151,762 156,242 164,068 114,738 114,382 104,826 21.53%
-
Tax Rate 32.45% 30.21% 27.51% 24.18% 35.80% 33.46% 34.07% -
Total Cost 1,084,732 1,053,137 981,210 902,528 760,297 762,705 749,518 27.80%
-
Net Worth 1,398,101 1,374,120 1,350,166 1,333,790 1,293,238 1,323,435 1,382,710 0.73%
Dividend
31/01/05 31/10/04 31/07/04 30/04/04 31/01/04 31/10/03 31/07/03 CAGR
Div 41,294 27,521 41,271 - 132,866 149,674 224,542 -67.49%
Div Payout % 29.36% 18.13% 26.42% - 115.80% 130.85% 214.21% -
Equity
31/01/05 31/10/04 31/07/04 30/04/04 31/01/04 31/10/03 31/07/03 CAGR
Net Worth 1,398,101 1,374,120 1,350,166 1,333,790 1,293,238 1,323,435 1,382,710 0.73%
NOSH 589,916 589,751 589,592 590,172 590,519 590,819 590,901 -0.11%
Ratio Analysis
31/01/05 31/10/04 31/07/04 30/04/04 31/01/04 31/10/03 31/07/03 CAGR
NP Margin 11.48% 12.60% 13.74% 15.38% 13.11% 13.04% 12.27% -
ROE 10.06% 11.04% 11.57% 12.30% 8.87% 8.64% 7.58% -
Per Share
31/01/05 31/10/04 31/07/04 30/04/04 31/01/04 31/10/03 31/07/03 CAGR
RPS 207.72 204.31 192.92 180.73 148.18 148.45 144.58 27.18%
EPS 23.84 25.73 26.50 27.80 19.43 19.36 17.74 21.66%
DPS 7.00 4.67 7.00 0.00 22.50 25.33 38.00 -67.45%
NAPS 2.37 2.33 2.29 2.26 2.19 2.24 2.34 0.84%
Adjusted Per Share Value based on latest NOSH - 590,172
31/01/05 31/10/04 31/07/04 30/04/04 31/01/04 31/10/03 31/07/03 CAGR
RPS 49.22 48.40 45.69 42.84 35.15 35.23 34.32 27.03%
EPS 5.65 6.10 6.28 6.59 4.61 4.59 4.21 21.55%
DPS 1.66 1.11 1.66 0.00 5.34 6.01 9.02 -67.47%
NAPS 0.5616 0.5519 0.5423 0.5357 0.5194 0.5316 0.5554 0.73%
Price Multiplier on Financial Quarter End Date
31/01/05 31/10/04 31/07/04 30/04/04 31/01/04 31/10/03 31/07/03 CAGR
Date 31/01/05 29/10/04 30/07/04 30/04/04 30/01/04 31/10/03 31/07/03 -
Price 0.83 0.80 0.88 0.88 0.90 0.83 0.74 -
P/RPS 0.40 0.39 0.46 0.49 0.61 0.56 0.51 -14.89%
P/EPS 3.48 3.11 3.32 3.17 4.63 4.29 4.17 -11.31%
EY 28.72 32.17 30.11 31.59 21.59 23.33 23.97 12.74%
DY 8.43 5.83 7.95 0.00 25.00 30.52 51.35 -69.85%
P/NAPS 0.35 0.34 0.38 0.39 0.41 0.37 0.32 6.12%
Price Multiplier on Announcement Date
31/01/05 31/10/04 31/07/04 30/04/04 31/01/04 31/10/03 31/07/03 CAGR
Date 31/03/05 09/12/04 28/09/04 22/06/04 31/03/04 10/12/03 24/09/03 -
Price 0.80 0.80 0.82 0.84 0.93 0.85 0.77 -
P/RPS 0.39 0.39 0.43 0.46 0.63 0.57 0.53 -18.41%
P/EPS 3.36 3.11 3.09 3.02 4.79 4.39 4.34 -15.62%
EY 29.80 32.17 32.32 33.10 20.89 22.78 23.04 18.61%
DY 8.75 5.83 8.54 0.00 24.19 29.80 49.35 -68.27%
P/NAPS 0.34 0.34 0.36 0.37 0.42 0.38 0.33 2.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment